Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 109.37B | 110.54B | 107.42B | 114.46B | 96.47B | 116.05B |
Gross Profit | 11.02B | 10.77B | 9.95B | 8.94B | 4.99B | 7.34B |
EBITDA | 4.61B | 4.43B | 4.27B | 3.42B | -315.00M | 2.01B |
Net Income | 3.41B | 2.90B | 2.65B | 1.91B | -1.59B | 335.00M |
Balance Sheet | ||||||
Total Assets | 80.90B | 80.67B | 80.62B | 79.67B | 82.19B | 84.47B |
Cash, Cash Equivalents and Short-Term Investments | 21.85B | 20.96B | 26.23B | 27.90B | 27.05B | 22.38B |
Total Debt | 748.00M | 674.00M | 822.00M | 971.00M | 1.18B | 6.39B |
Total Liabilities | 35.95B | 36.21B | 38.46B | 41.84B | 46.62B | 47.15B |
Stockholders Equity | 43.27B | 42.84B | 40.66B | 36.55B | 34.42B | 35.89B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -4.64B | -2.43B | 1.82B | 9.87B | -4.94B |
Operating Cash Flow | 0.00 | -4.38B | -2.09B | 2.17B | 11.52B | -4.54B |
Investing Cash Flow | 0.00 | -398.00M | -28.00M | -256.00M | -2.68B | 89.00M |
Financing Cash Flow | 0.00 | -891.00M | -801.00M | -776.00M | -5.74B | 4.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥23.77B | 7.92 | 1.19% | -14.89% | -28.68% | ||
80 Outperform | ¥34.61B | 12.03 | 5.82% | 2.36% | 136.83% | ||
76 Outperform | ¥23.21B | 8.76 | 3.92% | -1.95% | 37.71% | ||
74 Outperform | ¥24.85B | 8.56 | 3.04% | 2.91% | 9.79% | ||
72 Outperform | ¥30.76B | 8.78 | 2.79% | -0.26% | 28.01% | ||
65 Neutral | $10.65B | 15.52 | 5.51% | 1.92% | 2.72% | -26.34% | |
65 Neutral | ¥23.76B | 7.41 | 2.59% | -4.84% | -16.53% |